AI & ChatGPT searches , social queries for PF 184563

AI searches containing PF 184563

PF 184563

• PF-184563

Chemical compound

PF-184563 is a potent, selective non-peptidic antagonist of the V1a receptor. The compound was discovered by Pfizer in its Sandwich, Kent research center

PF-184563



PF-184563

• SRX251

Pharmaceutical compound

clinical trials. List of investigational aggression drugs SRX246 Balovaptan PF-184563 Relcovaptan RG7713 "SRX 251". AdisInsight. 3 January 2024. Retrieved 24

SRX251



SRX251

• Tolvaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Tolvaptan



Tolvaptan

• Desmopressin

Medication

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Desmopressin



Desmopressin

• Lithium carbonate

Chemical compound

Retrieved 2017-01-02. Yildiz, A; Guleryuz, S; Ankerst, DP; Ongür, D; Renshaw, PF (2008). "Protein kinase C inhibition in the treatment of mania: a double-blind

Lithium carbonate



Lithium_carbonate

• PF-06655075

Pharmaceutical compound

PF-06655075, also known as PF1 or as ASK1476, is a peripherally selective long-acting peptide oxytocin receptor agonist which is used in scientific research

PF-06655075

PF-06655075

• Vasopressin

Mammalian hormone released from the pituitary gland

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin



Vasopressin

• KNX-100

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

KNX-100



KNX-100

• Cligosiban

Pharmaceutical compound

(INNTooltip International Nonproprietary Name; developmental code names IX-01 and PF-3274167) is an oxytocin receptor antagonist which is or was under development

Cligosiban



Cligosiban

• Carbetocin

Medication used for preventing postpartum bleeding

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Carbetocin



Carbetocin

• Vasopressin (medication)

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin (medication)



Vasopressin_(medication)

• Oxytocin receptor agonist

Chemical compound

Carbetocin Demoxytocin Lipo-oxytocin-1 (LOT-1) Merotocin (FE-202767) Oxytocin PF-06655075 (PF1; ASK1476) TGOT Vasotocin CA7 – among smallest-known oxytocin

Oxytocin receptor agonist



Oxytocin_receptor_agonist

• KNX-101

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

KNX-101

KNX-101

• Oxytocin (medication)

Medication made from the peptide oxytocin

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Oxytocin (medication)



Oxytocin_(medication)

• Oxytocin

Peptide hormone and neuropeptide

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Oxytocin



Oxytocin

• Demeclocycline

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Demeclocycline



Demeclocycline

• Barusiban

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Barusiban



Barusiban

• Ornipressin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Ornipressin



Ornipressin

• Nelivaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Nelivaptan



Nelivaptan

• Terlipressin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Terlipressin



Terlipressin

• LIT-001

Small-molecule oxytocin receptor agonist

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

LIT-001



LIT-001

• Vasopressin receptor antagonist

Agent that interferes with action at the vasopressin receptors

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin receptor antagonist

Vasopressin_receptor_antagonist

• NTX-1472

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

NTX-1472

NTX-1472

• SRX246

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

SRX246



SRX246

• Atosiban

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Atosiban



Atosiban

• LIT-002

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

LIT-002



LIT-002

• TGOT

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

TGOT

TGOT

• Vasotocin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasotocin



Vasotocin

• Selepressin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Selepressin



Selepressin

• WAY-267464

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

WAY-267464



WAY-267464

• Uterotonic

Medication causing uterine contraction

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Uterotonic

Uterotonic

• TC OT 39

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

TC OT 39



TC_OT_39

• Tocinoic acid

Oxytocin receptor antagonist

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Tocinoic acid



Tocinoic_acid

• Retosiban

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Retosiban



Retosiban

• Oxytocin receptor

Genes on human chromosome 3

Carbetocin Demoxytocin Lipo-oxytocin-1 (LOT-1) Merotocin (FE-202767) Oxytocin PF-06655075 (PF1; ASK1476) TGOT Vasotocin CA7 – among smallest-known oxytocin

Oxytocin receptor



Oxytocin_receptor

• OT-12

Pharmaceutical compound

literature by Elsa Pflimlin and colleagues by 2020. Oxytocin receptor agonist PF-06655075 (PF1; ASK1476) Pflimlin E, Zhou Z, Amso Z, Fu Q, Lee C, Muppiddi

OT-12

OT-12

• Vasopressin receptor 2

Protein-coding gene in the species Homo sapiens

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin receptor 2



Vasopressin_receptor_2

• L-368,899

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

L-368,899



L-368,899

• Demoxytocin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Demoxytocin



Demoxytocin

• Brezivaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Brezivaptan



Brezivaptan

• Conivaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Conivaptan



Conivaptan

• Epelsiban

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Epelsiban



Epelsiban

• Felypressin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Felypressin



Felypressin

• Vasopressin receptor 1B

Protein-coding gene in the species Homo sapiens

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin receptor 1B



Vasopressin_receptor_1B

• WJ0679

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

WJ0679



WJ0679

• Relcovaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Relcovaptan



Relcovaptan

• CA7 (drug)

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

CA7 (drug)



CA7_(drug)

• Neurophysin I

Cleavage product of the coding protein of OXT gene

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Neurophysin I

Neurophysin_I

• NP-1031

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

NP-1031

NP-1031

• Vasopressin receptor

G protein-coupled receptor

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin receptor

Vasopressin_receptor

• Neurophysins

Carrier protein for oxytocin and vasopressin

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Neurophysins

Neurophysins

• Balovaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Balovaptan



Balovaptan

• Vasopressin receptor 1A

Protein-coding gene in the species Homo sapiens

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Vasopressin receptor 1A



Vasopressin_receptor_1A

• Nolasiban

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Nolasiban



Nolasiban

• Lixivaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Lixivaptan



Lixivaptan

• RG7713

Vasopressin V1A receptor antagonist

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

RG7713



RG7713

• Merotocin

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Merotocin



Merotocin

• NMRA-511

Pharmaceutical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

NMRA-511

NMRA-511

• Neurophysin II

Cleavage product of the arginine vasopressin gene

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Neurophysin II



Neurophysin_II

• Mozavaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Mozavaptan



Mozavaptan

• Satavaptan

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Satavaptan



Satavaptan

• Lipo-oxytocin-1

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

Lipo-oxytocin-1



Lipo-oxytocin-1

• L-371,257

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

L-371,257



L-371,257

• ABT-436

Chemical compound

JNJ-17079166 JNJ-17308616 LIT-001 LY-307174 NMRA-511 NTX-1472 (RO-6953958) PF-184563 Relcovaptan RG7713 SRX246 SRX251 TC OT 39 WAY-267464 YM-218 YM-471 YM-35471

ABT-436

ABT-436

AI & ChatGPT searchs for online references containing PF 184563

PF 184563

AI search references containing PF 184563

PF 184563

AI search queries for Facebook and twitter posts, hashtags with PF 184563

PF 184563

Follow users with usernames @PF 184563 or posting hashtags containing #PF 184563

PF 184563

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with PF 184563

PF 184563

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing PF 184563

PF 184563

AI searchs for Acronyms & meanings containing PF 184563

PF 184563

Other words and meanings similar to

PF 184563

AI search in online dictionary sources & meanings containing PF 184563

PF 184563